Lawrence Fleckenstein

3.8k total citations
90 papers, 2.7k citations indexed

About

Lawrence Fleckenstein is a scholar working on Public Health, Environmental and Occupational Health, Infectious Diseases and Pharmacology. According to data from OpenAlex, Lawrence Fleckenstein has authored 90 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Public Health, Environmental and Occupational Health, 25 papers in Infectious Diseases and 25 papers in Pharmacology. Recurrent topics in Lawrence Fleckenstein's work include Malaria Research and Control (25 papers), Parasitic Diseases Research and Treatment (19 papers) and Parasites and Host Interactions (16 papers). Lawrence Fleckenstein is often cited by papers focused on Malaria Research and Control (25 papers), Parasitic Diseases Research and Treatment (19 papers) and Parasites and Host Interactions (16 papers). Lawrence Fleckenstein collaborates with scholars based in United States, Switzerland and Thailand. Lawrence Fleckenstein's co-authors include Isabelle Borghini-Fuhrer, Stephan Duparc, Chang-Sik Shin, J D Chulay, Carrie A. Morris, Donald Jung, Thomas G. Brewer, Melvin H. Heiffer, James O. Peggins and Sarah Arbe‐Barnes and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Lawrence Fleckenstein

87 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lawrence Fleckenstein United States	29	1.3k	678	664	470	376	90	2.7k
T Harinasuta Thailand	33	2.5k 2.0×	354 0.5×	885 1.3×	726 1.5×	403 1.1×	152	3.9k
Steffen Borrmann Germany	30	2.0k 1.6×	342 0.5×	630 0.9×	354 0.8×	457 1.2×	93	3.0k
Jacques Chollet Switzerland	32	1.4k 1.1×	210 0.3×	1.5k 2.2×	266 0.6×	372 1.0×	53	3.1k
S Looareesuwan Thailand	32	2.6k 2.0×	311 0.5×	628 0.9×	540 1.1×	433 1.2×	73	3.3k
Peter J. Weina United States	25	1.7k 1.3×	259 0.4×	312 0.5×	273 0.6×	261 0.7×	63	2.3k
H. Kyle Webster Thailand	36	3.1k 2.4×	515 0.8×	720 1.1×	400 0.9×	340 0.9×	122	4.4k
Srivicha Krudsood Thailand	29	2.3k 1.8×	349 0.5×	563 0.8×	332 0.7×	289 0.8×	118	3.1k
S. Looareesuwan Thailand	29	2.7k 2.1×	303 0.4×	365 0.5×	595 1.3×	544 1.4×	36	3.7k
Karl H. Rieckmann Australia	37	3.8k 3.0×	738 1.1×	623 0.9×	753 1.6×	650 1.7×	136	5.1k
Juntra Karbwang Thailand	38	3.0k 2.4×	424 0.6×	371 0.6×	973 2.1×	480 1.3×	165	4.7k

Countries citing papers authored by Lawrence Fleckenstein

Since Specialization

Citations

This map shows the geographic impact of Lawrence Fleckenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence Fleckenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence Fleckenstein more than expected).

Fields of papers citing papers by Lawrence Fleckenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence Fleckenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence Fleckenstein. The network helps show where Lawrence Fleckenstein may publish in the future.

Co-authorship network of co-authors of Lawrence Fleckenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence Fleckenstein. A scholar is included among the top collaborators of Lawrence Fleckenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence Fleckenstein. Lawrence Fleckenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ramharter, Michael, Abdoulaye Djimdé, Isabelle Borghini-Fuhrer, et al.. (2024). Safety and efficacy of pyronaridine–artesunate paediatric granules in the treatment of uncomplicated malaria in children: insights from randomized clinical trials and a real-world study. Malaria Journal. 23(1). 61–61.

Jamsen, Kris M., Carl M. J. Kirkpatrick, Nicholas Opoku, et al.. (2017). DETERMINING THE OPTIMAL DOSE OF MOXIDECTIN FOR ONCHOCERCIASIS VIA PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELLING OF DATA FROM HEALTHY VOLUNTEERS AND PATIENTS WITH ONCHOCERCIASIS. American Journal of Tropical Medicine and Hygiene. 97(5). 238–239. 3 indexed citations

Methaneethorn, Janthima, Michael Ramharter, Abdoulaye Djimdé, et al.. (2015). Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients. Antimicrobial Agents and Chemotherapy. 60(3). 1450–1458. 16 indexed citations

Bastiaens, Guido J. H., Alfred B. Tiono, Wamdaogo M. Guelbéogo, et al.. (2014). Efficacy and Safety of the Mosquitocidal Drug Ivermectin to Prevent Malaria Transmission After Treatment: A Double-Blind, Randomized, Clinical Trial. Clinical Infectious Diseases. 60(3). 357–365. 83 indexed citations

Korth‐Bradley, Joan, Virginia Parks, Frank Wagner, et al.. (2013). Effect of moxidectin on CYP3A4 activity as evaluated by oral midazolam pharmacokinetics in healthy subjects. Clinical Pharmacology in Drug Development. 3(2). 151–157. 15 indexed citations

Grein, Jonathan, Glenn E. Mathisen, Suzanne Donovan, & Lawrence Fleckenstein. (2010). Serum ivermectin levels after enteral and subcutaneous administration for Strongyloides hyperinfection: A case report. Scandinavian Journal of Infectious Diseases. 42(3). 234–236. 19 indexed citations

Naik, Himanshu, In‐Jin Jang, Kyung‐Sang Yu, et al.. (2009). Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects. Malaria Journal. 8(1). 304–304. 18 indexed citations

Ramharter, Michael, Florian Kurth, Johannes Nemeth, et al.. (2008). Fixed‐Dose Pyronaridine‐Artesunate Combination for Treatment of Uncomplicated Falciparum Malaria in Pediatric Patients in Gabon. The Journal of Infectious Diseases. 198(6). 911–919. 86 indexed citations

Leung, Vyl, et al.. (2008). Failure of Subcutaneous Ivermectin in Treating Strongyloides Hyperinfection. American Journal of Tropical Medicine and Hygiene. 79(6). 853–855. 16 indexed citations

10.

Marty, Francisco M., María J. Rodríguez, Danny A. Milner, et al.. (2005). Treatment of Human Disseminated Strongyloidiasis with a Parenteral Veterinary Formulation of Ivermectin. Clinical Infectious Diseases. 41(1). e5–e8. 71 indexed citations

11.

Kshirsagar, Nilima, Nithya Gogtay, BS Garg, et al.. (2004). Safety, tolerability, efficacy and plasma concentrations of diethylcarbamazine and albendazole co-administration in a field study in an area endemic for lymphatic filariasis in India. Transactions of the Royal Society of Tropical Medicine and Hygiene. 98(4). 205–217. 25 indexed citations

12.

Chen, Ya‐Chi, et al.. (2002). Liquid chromatographic assay of moxidectin in human plasma for application to pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 29(5). 917–926. 23 indexed citations

13.

Shenoy, R. K., Takeshi Suma, Anil John, et al.. (2002). The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole. Annals of Tropical Medicine and Parasitology. 96(6). 603–614. 30 indexed citations

14.

Fleckenstein, Lawrence, et al.. (2002). Pharmacokinetics and dose proportionality of oral moxidectin in beagle dogs. Biopharmaceutics & Drug Disposition. 23(7). 263–272. 36 indexed citations

15.

Fleckenstein, Lawrence, et al.. (2002). HPLC assay for albendazole and metabolites in human plasma for clinical pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 30(3). 801–813. 65 indexed citations

16.

Fleckenstein, Lawrence, et al.. (2001). Gas chromatographic assay of diethylcarbamazine in human plasma for application to clinical pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 26(4). 665–674. 8 indexed citations

17.

Min, David I., et al.. (1999). A Urine Metabolic Ratio of Dextromethorphan and 3‐Methoxymorphinan as a Probe for CYP3A Activity and Prediction of Cyclosporine Clearance in Healthy Volunteers. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(6). 753–759. 15 indexed citations

18.

Peggins, James O., et al.. (1998). The Pharmacokinetics and Bioavailability of Dihydroartemisinin, meether, Artemether, Artesunic Acid and Artelinic Acid in Rats. Journal of Pharmacy and Pharmacology. 50(2). 173–182. 142 indexed citations

19.

Umeh, Rich, et al.. (1998). Clinical pharmacokinetics of suramin in patients with onchocerciasis. European Journal of Clinical Pharmacology. 54(3). 249–251. 11 indexed citations

20.

Coleman, Michael D., Lawrence Fleckenstein, & Melvin H. Heiffer. (1989). Primaquine disposition in the isolated perfused rat liver: Effect of mefloquine induced bile flow reduction. Biopharmaceutics & Drug Disposition. 10(2). 153–164. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact